RETRACTED ARTICLE: miR-647 inhibits hepatocellular carcinoma cell progression by targeting protein tyrosine phosphatase receptor type F
Authors:
Open Access
- 30 December 2021
- journal article
- retracted article
- Published by Taylor & Francis in Bioengineered
- Vol. 13 (1) , 1090-1102
Abstract
Hepatocellular carcinoma (HCC) is a kind of malignant tumor derived from hepatocytes and hepatobiliary cells, and its occurrence is prevalent worldwide. Although medical technology is developing rapidly, the therapeutic efficacy of HCC is still poor. Emerging evidence manifests that microRNAs (miRNAs) play a crucial role in various cancers and have been regarded as cancer suppressor gene. However, the regulatory mechanisms mediated by miR-647 involved in HCC remain unclear. Hence, to clarify the regulatory mechanisms mediated by miR-647 in HCC, we studied the independent effects of miR-647 and explored protein tyrosine phosphatase receptor type F (PTPRF) in the constructed HCC cell line (HCV-huh7.5). Thereafter, we used dual-luciferase gene reporting and Western blot to investigate the relationship between PTPRF and miR-647. Furthermore, we studied the mechanism of miR-647 on PTPRF in HCV-huh7.5. We found that miR-647 could not only promote the proliferation and invasion of HCV-huh7.5 cells but also facilitate cell migration, while PTPRF has the opposite effect. Besides, the results of cell function experiment implied that the overexpression of miR-647 or inhibition of PTPFRF remarkably influenced the Erk signaling pathway, which could regulate cell proliferation, migration, and invasion. In addition, the dual luciferase reporting identified PTPRF as a direct target of miR-647. We further demonstrated that miR-647 inhibitor or PTPRF knockdown administration boosted HCV-huh7.5 cell proliferation, migration, and invasion by targeting PTPRF. These findings provided clues for the mechanism of miR-647 in promoting the biology of HCV-huh7.5 cells by inhibiting the expression level of PTPRF.Keywords
Funding Information
- Putian University science and Technology project (2021046)
This publication has 43 references indexed in Scilit:
- Hepatocellular carcinoma: From diagnosis to treatmentSurgical Oncology, 2016
- Exploring miRNA based approaches in cancer diagnostics and therapeuticsCritical Reviews in Oncology/Hematology, 2016
- Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient managementBreast Cancer Research, 2015
- The use of the Gail model, body mass index and SNPs to predict breast cancer among women with abnormal (BI-RADS 4) mammogramsBreast Cancer Research, 2015
- Dysregulated Serum MicroRNA Expression Profile and Potential Biomarkers in Hepatitis C Virus-infected PatientsInternational Journal of Medical Sciences, 2015
- MiR-520d-5p directly targets TWIST1 and downregulates the metastamiR miR-10bOncotarget, 2014
- MicroRNAs in cancer: biomarkers, functions and therapyTrends in Molecular Medicine, 2014
- Functional genomics identified a novel protein tyrosine phosphatase receptor type f-mediated growth inhibition in hepatocarcinogenesisHepatology, 2014
- MicroRNA miR-24 Enhances Tumor Invasion and Metastasis by Targeting PTPN9 and PTPRF to Promote EGF SignalingJournal of Cell Science, 2013
- The Regulation of AP-1 Activity by Mitogen-activated Protein KinasesJournal of Biological Chemistry, 1995